Literature DB >> 14557646

The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein.

Andrea Bertolotti-Ciarlet1, Sue E Crawford, Anne M Hutson, Mary K Estes.   

Abstract

Norwalk virus (NV) is the prototype strain of a group of noncultivable human caliciviruses responsible for epidemic outbreaks of acute gastroenteritis. The capsid protein VP1 is synthesized from a subgenomic RNA that contains two open reading frames (ORFs), ORF2 and ORF3, and the 3' untranslated region (UTR). ORF2 and ORF3 code for the capsid protein (VP1) and a small structural basic protein (VP2), respectively. We discovered that the yields of virus-like particles (VLPs) composed of VP1 are significantly reduced when this protein is expressed from ORF2 alone. To determine how the 3' terminus of the NV subgenomic RNA regulates VP1 expression, we compared VP1 expression levels by using recombinant baculovirus constructs containing different 3' elements. High VP1 levels were detected by using a recombinant baculovirus that contained ORF2, ORF3, and the 3'UTR (ORF2+3+3'UTR). In contrast, expression of VP1 from constructs that lacked the 3'UTR (ORF2+3), ORF3 (ORF2+3'UTR), or both (ORF2 alone) was highly reduced. Elimination of VP2 synthesis from the subgenomic RNA by mutation resulted in VP1 levels similar to those obtained with the ORF2 construct alone, suggesting a cis role for VP2 in upregulation of VP1 expression levels. Comparisons of the kinetics of RNA and capsid protein expression levels by using constructs with or without ORF3 or the 3'UTR revealed that the 3'UTR increased the levels of VP1 RNA, whereas the presence of VP2 resulted in increased levels of VP1. Furthermore, VP2 increased VP1 stability and protected VP1 from disassembly and protease degradation. The increase in VP1 expression levels caused by the presence of VP2 in cis was also observed in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557646      PMCID: PMC229252          DOI: 10.1128/jvi.77.21.11603-11615.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Identification of a cis-acting replication element within the poliovirus coding region.

Authors:  I Goodfellow; Y Chaudhry; A Richardson; J Meredith; J W Almond; W Barclay; D J Evans
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  cis-acting elements within an RNA coliphage genome: fold as you please, but fold you must!!

Authors:  R Arora; C Priano; A B Jacobson; D R Mills
Journal:  J Mol Biol       Date:  1996-05-10       Impact factor: 5.469

3.  Structure and function of rotavirus nonstructural protein NSP3.

Authors:  D Poncet; C Aponte; J Cohen
Journal:  Arch Virol Suppl       Date:  1996

4.  Autoregulated instability of beta-tubulin mRNAs by recognition of the nascent amino terminus of beta-tubulin.

Authors:  T J Yen; P S Machlin; D W Cleveland
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

5.  The 3' end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp).

Authors:  S Agrawal; D Gupta; S K Panda
Journal:  Virology       Date:  2001-03-30       Impact factor: 3.616

6.  Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies.

Authors:  M E Hardy; T N Tanaka; N Kitamoto; L J White; J M Ball; X Jiang; M K Estes
Journal:  Virology       Date:  1996-03-01       Impact factor: 3.616

7.  Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein.

Authors:  X Jiang; D O Matson; G M Ruiz-Palacios; J Hu; J Treanor; L K Pickering
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

8.  Rotavirus RNA-binding protein NSP3 interacts with eIF4GI and evicts the poly(A) binding protein from eIF4F.

Authors:  M Piron; P Vende; J Cohen; D Poncet
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

9.  Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography.

Authors:  P S Furcinitti; J van Oostrum; R M Burnett
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

Review 10.  Comparison of the replication of positive-stranded RNA viruses of plants and animals.

Authors:  K W Buck
Journal:  Adv Virus Res       Date:  1996       Impact factor: 9.937

View more
  74 in total

1.  Divergent evolution of norovirus GII/4 by genome recombination from May 2006 to February 2009 in Japan.

Authors:  Kazushi Motomura; Masaru Yokoyama; Hirotaka Ode; Hiromi Nakamura; Hiromi Mori; Tadahito Kanda; Tomoichiro Oka; Kazuhiko Katayama; Mamoru Noda; Tomoyuki Tanaka; Naokazu Takeda; Hironori Sato
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

2.  Covariation of major and minor viral capsid proteins in norovirus genogroup II genotype 4 strains.

Authors:  Martin Chi-Wai Chan; Nelson Lee; Wing-Shan Ho; Carmen Oi-Kwan Law; Terrence Chi-Kong Lau; Stephen Kwok-Wing Tsui; Joseph Jao-Yiu Sung
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Norwalk virus assembly and stability monitored by mass spectrometry.

Authors:  Glen K Shoemaker; Esther van Duijn; Sue E Crawford; Charlotte Uetrecht; Marian Baclayon; Wouter H Roos; Gijs J L Wuite; Mary K Estes; B V Venkataram Prasad; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2010-04-22       Impact factor: 5.911

5.  Crystallization and preliminary X-ray diffraction analysis of the protease from Southampton norovirus complexed with a Michael acceptor inhibitor.

Authors:  R J Hussey; L Coates; R S Gill; J N Wright; M Sarwar; S Coker; P T Erskine; J B Cooper; S Wood; I N Clarke; P R Lambden; R Broadbridge; P M Shoolingin-Jordan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-29

6.  Inactivation of a human norovirus surrogate by high-pressure processing: effectiveness, mechanism, and potential application in the fresh produce industry.

Authors:  Fangfei Lou; Hudaa Neetoo; Haiqiang Chen; Jianrong Li
Journal:  Appl Environ Microbiol       Date:  2010-12-30       Impact factor: 4.792

7.  Molecular characterization of three novel murine noroviruses.

Authors:  Charlie C Hsu; Lela K Riley; Robert S Livingston
Journal:  Virus Genes       Date:  2006-12-15       Impact factor: 2.332

8.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

9.  The importance of intergenic recombination in norovirus GII.3 evolution.

Authors:  Jackie E Mahar; Karin Bok; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Recombination within the pandemic norovirus GII.4 lineage.

Authors:  John-Sebastian Eden; Mark M Tanaka; Maciej F Boni; William D Rawlinson; Peter A White
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.